Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared a post on LinkedIn:
“Press release:
Finally: One more option for patients with Pancreas Cancer, and promising for other cancers who have KRAS.
Overall Survival:
DaraxonRASib(RMC-6236)
13.2 months
Chemotherapy
6.7 months
Hazard ratio of 0.40 (p < 0.0001).”
Other articles featuring Pashtoon Kasi on OncoDaily.